These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2497455

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Management of malignant pleural effusion by tetracycline pleurodesis].
    Horváth T, Orosz E, Czenkár B.
    Orv Hetil; 1989 May 14; 130(20):1051-2. PubMed ID: 2471952
    [Abstract] [Full Text] [Related]

  • 3. [Fibrin glue pleurodesis in recurrent malignant pleural effusions].
    Gust R, Fabel H.
    Pneumologie; 1989 Feb 14; 43(2):85-7. PubMed ID: 2470081
    [Abstract] [Full Text] [Related]

  • 4. [Pleurodesis technics].
    Guérin JC, Boniface E.
    Rev Prat; 1990 Sep 11; 40(20):1854-6. PubMed ID: 2218351
    [Abstract] [Full Text] [Related]

  • 5. [Fibrin glue and tetracycline pleurodesis in recurrent malignant pleural effusions. A randomized comparative study].
    Gust R, Kleine P, Fabel H.
    Med Klin (Munich); 1990 Jan 15; 85(1):18-23. PubMed ID: 1690342
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic pleurodesis in spontaneous pneumothorax, malignant pleural effusion, heart insufficiency and chylothorax].
    Storm HK, Viskum K.
    Ugeskr Laeger; 1991 Apr 01; 153(14):989-92. PubMed ID: 2024319
    [Abstract] [Full Text] [Related]

  • 7. [Pleural effusion].
    Thomas P, Castelnau O, Kleisbauer JP.
    Rev Mal Respir; 1998 Jun 01; 15(3 Pt 2):363-7. PubMed ID: 9690306
    [Abstract] [Full Text] [Related]

  • 8. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
    Martínez Moragón E, Aparicio Urtasun J, Sanchis Aldás J, Fullana Monllor J, Sanchis Moret F, Montalar Salcedo J, Marco Martínez V.
    Med Clin (Barc); 1993 Jul 03; 101(6):201-4. PubMed ID: 8332018
    [Abstract] [Full Text] [Related]

  • 9. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
    Akopov AL, Egorov VI, Varlamov VV, Levashev YN, Artioukh DY.
    Eur J Cardiothorac Surg; 2005 Nov 03; 28(5):750-3. PubMed ID: 16198593
    [Abstract] [Full Text] [Related]

  • 10. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.
    Steger V, Mika U, Toomes H, Walker T, Engel C, Kyriss T, Ziemer G, Friedel G.
    Ann Thorac Surg; 2007 Jun 03; 83(6):1940-5. PubMed ID: 17532375
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G, Sichletidis L, Spyratos D, Chloros D, Zarogoulidis K, Kontakiotis T, Bagalas V, Porpodis K, Manika K, Patakas D.
    Am J Clin Oncol; 2008 Aug 03; 31(4):384-9. PubMed ID: 18845999
    [Abstract] [Full Text] [Related]

  • 12. Current trends in pleurodesis.
    Rodriguez-Panadero F.
    Curr Opin Pulm Med; 1997 Jul 03; 3(4):319-25. PubMed ID: 9262121
    [Abstract] [Full Text] [Related]

  • 13. Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
    Neragi-Miandoab S.
    Lung Cancer; 2006 Oct 03; 54(1):1-9. PubMed ID: 16893591
    [Abstract] [Full Text] [Related]

  • 14. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
    Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN.
    J Thorac Cardiovasc Surg; 1993 Apr 03; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
    [Abstract] [Full Text] [Related]

  • 15. Thoracoscopic management of malignant pleural effusions.
    Colt HG.
    Clin Chest Med; 1995 Sep 03; 16(3):505-18. PubMed ID: 8521705
    [Abstract] [Full Text] [Related]

  • 16. [Thoracoscopy in malignant pleural effusions].
    Zhang D, Chen Y, Tu C.
    Zhonghua Zhong Liu Za Zhi; 1996 Mar 03; 18(2):123-6. PubMed ID: 9206045
    [Abstract] [Full Text] [Related]

  • 17. [Pleurodesis with tetracyclines after fontan operation].
    Torres Borrego J, Nieves Martínez Gil C, Pérez Ruiz E, Pérez Frías J, Martínez Valverde A.
    An Esp Pediatr; 2001 Jul 03; 55(1):76-9. PubMed ID: 11412475
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature.
    Breuer GS, Deeb M, Fisher D, Nesher G.
    Semin Arthritis Rheum; 2005 Apr 03; 34(5):744-9. PubMed ID: 15846590
    [Abstract] [Full Text] [Related]

  • 19. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A, Natali P, Casali C, Morandi U.
    Eur J Cardiothorac Surg; 2006 Dec 03; 30(6):827-32. PubMed ID: 17113008
    [Abstract] [Full Text] [Related]

  • 20. [VATS in malignant pleural effusions].
    Cui Y, Wang J, Liu T.
    Zhonghua Wai Ke Za Zhi; 1997 Nov 03; 35(11):675-6. PubMed ID: 10678010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.